OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Antimicrobial Resistance in ESKAPE Pathogens	893
Coronavirus Disease 2019–COVID-19	651
New β-Lactam–β-Lactamase Inhibitor Combinations	246
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection	193
Remdesivir against COVID-19 and Other Viral Diseases	168
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	138
Antifungal Susceptibility Testing: Current Approaches	136
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection	133
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis	120
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory	118
Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries	104
Host-Directed Antiviral Therapy	102
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	95
Yersinia pestis: the Natural History of Plague	91
Pathogenesis of Gram-Negative Bacteremia	89
Convalescent Plasma Therapy for COVID-19: State of the Art	86
Microsporidiosis in Humans	86
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and	80
Viral Respiratory Pathogens and Lung Injury	76
Advances in the Microbiology of Stenotrophomonas maltophilia	75
Evolutionary Pathways and Trajectories in Antibiotic Resistance	72
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis	70
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies	67
Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products	65
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis	63

Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters	63
Pathogenesis of Respiratory Viral and Fungal Coinfections	62
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	62
Laboratory Diagnosis of Lyme Borreliosis	59
Intrathecal Antibacterial and Antifungal Therapies	59
SARS-CoV-2 Antiviral Therapy	58
Taenia solium Cysticercosis and Its Impact in Neurological Disease	54
Giardia duodenalis: Biology and Pathogenesis	53
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries	53
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	47
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices	43
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation	43
Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential	41
SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles	41
Human Listeriosis	39
Staphylococcus aureus in Agriculture: Lessons in Evolution from a Multispecies Pathogen	37
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections	37
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	37
Interplay between Candida albicans and Lactic Acid Bacteria in the Gastrointestinal Tract: Impact on Colonization Resistance, Microbial Carriage, Opportunistic Infection, and Host Immunity	34
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	34
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation	33
Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients	33
Device-Associated Menstrual Toxic Shock Syndrome	31
State of the Art in the Culture of the Human Microbiota: New Interests and Strategies	31
The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications	31
Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance	30
Canine and Feline Parasitology: Analogies, Differences, and Relevance for Human Health	30
Understanding the Impact of Resistance to Influenza Antivirals	29
Updated Review onNocardiaSpecies: 2006–2021	29
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis	27
Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks	27
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection	26
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	26
Monkeypox Virus Infections in Humans	25
Echinococcoses in Iran, Turkey, and Pakistan: Old Diseases in the New Millennium	24
Aspergillus terreus Species Complex	24
Paracoccidioidomycosis: Current Status and Future Trends	24
SARS-CoV-2 Infection and Lung Regeneration	24
Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection	23
The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures	22
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	21
Erratum for Ramasamy and Subbian, “Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis”	20
Erratum for Yahav et al., “New β-Lactam–β-Lactamase Inhibitor Combinations”	19
Group B Streptococcal Neonatal Meningitis	19
Antiviral Approaches against Influenza Virus	19
Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use	19
Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy	18
Diagnosis, Management, and Future Control of Cholera	17
Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections	16
Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases	15

Class C β-Lactamases: Molecular Characteristics	15
Natural-Product-Based Solutions for Tropical Infectious Diseases	15